Our research team focuses on developing fundamental technologies to control bio-interfaces formed by implantable biomaterials and devices within the human body. By securing these core technologies, we aim to enhance the safety and functionality of biomaterials and biomedical devices. Our ultimate goal is to establish an integrated Bio-Interface Control Technology that maximizes diagnostic and therapeutic efficacy, leading to the development and commercialization of advanced implantable biomaterials and systems through translational research.